Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$57.8M Sell
163,100
-130,000
-44% -$34.6M 0.01% 1602
2026
Q1
$44.3M Sell
293,100
-185,200
-39% -$22.5M 0.01% 1765
2025
Q4
$52.3M Buy
478,300
+249,200
+109% +$36.2M 0.01% 1576
2025
Q3
$32.4M Sell
229,100
-177,000
-44% -$25.8M 0.01% 2049
2025
Q2
$65.7M Sell
406,100
-5,374
-1% -$667K 0.01% 1275
2025
Q1
$43.9M Buy
411,474
+109,512
+36% +$15.3M 0.01% 1600
2024
Q4
$37.3M Buy
301,962
+231,962
+331% +$32.7M 0.01% 1721
2024
Q3
$10M Sell
70,000
-29,400
-30% -$4.18M ﹤0.01% 2367
2024
Q2
$16.3M Sell
99,400
-66,600
-40% -$8.28M ﹤0.01% 1846
2024
Q1
$20.7M Buy
+166,000
New +$17.6M 0.01% 1655

Other funds holding ARM

UBS Group's ARM Position: Q2 2026 in Review

UBS Group reduced its Arm (ARM) stake by 1.7% in Q2 2026, selling an estimated $7.51M and leaving 1,648,810 shares worth $585M. The position accounts for 0.07% of the portfolio, ranked #249.

UBS Group first reported a position in ARM in Q3 2023 and has held it in 12 quarters since. 957 funds tracked by Wall St. Rank hold ARM as of Q2 2026.

  • UBS Group held 1,648,810 shares of Arm worth $585M as of Q2 2026.
  • UBS Group sold 28,235 Arm shares in Q2 2026, an estimated $7.51M.
  • Arm made up 0.07% of UBS Group's portfolio in Q2 2026, its #249 holding.
  • UBS Group first reported a position in Arm in Q3 2023 and has held it in 12 quarters since.
  • 957 funds tracked by Wall St. Rank held Arm as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.